Hubei Cancer HospitalIvonescimabluminal-type breast cancerNCT06402435chemotherapyImmunotherapyneoadjuvant SBRTstereotactic body radiotherapy
…ination This study has been approved by the ethics committee of Hubei Cancer Hospital (Approval No.: LCKY2024011). Results will be disseminated throu…